How to Implement Evidence Into Practice to Improve Diabetes Care

Ilag, Liza L.; Herman, William H.
March 2004
Diabetes Care;Mar2004, Vol. 27 Issue 3, p850
Academic Journal
Presents a comment on the study related to the treatment of diabetes disease. Analysis on the blood samples of the patients; Control of glucose level; Effects of diabetes on the cardiovascular system of the patients.


Related Articles

  • Diabetes mellitus -- part four.  // GP: General Practitioner;5/19/2003, p54 

    There is increasing evidence to confirm that meticulous glycemic control can prevent or delay the onset of complications of the disease diabetes. There are two important studies, 'Diabetes Control and Complications Trial' (DCCT) and 'UK Prospective Diabetes Study (UKPDS). DCCT demonstrated that...

  • Will relaxing QOF Hba1c target harm care of patients with diabetes? Hadley-Brown, Martin // Pulse;9/15/2010, Vol. 70 Issue 26, p16 

    In this article, the authors offer views on whether the quality and outcome framework (QOF) for hemoglobin A1c test would harm the care of diabetics. One of the authors mentions that moving the test target might let some patients miss out the best health care. One of the authors states that the...

  • Pharmacies 'should offer diabetes test'  // Pulse;5/3/2004, Vol. 64 Issue 18, p8 

    Reports that most general physicians want pharmacies to offer blood tests for diagnosing type-2 diabetes in Great Britain. Suitability of pharmacies to conduct diagnostic tests for diabetes.

  • Mild glucose intolerance in pregnancy may be linked to increased risk of CV disease.  // Contemporary OB/GYN;Dec2009, Vol. 54 Issue 12, p14 

    The article discusses a study in 435,000 Canadian women with ages 20-49 years who have delivered live fetus from April 1994 to March 1998 and who have no pregestational diabetes. It states that 72,000 of the women were given oral glucose tolerance test due to an abnormal result in their glucose...

  • Coronary vasomotor abnormalities in insulin-resistant individuals. Qui&numl;ones, Manuel J.; Hemandez-Pampaloni, Miguel; Schelbert, Heinrich; Bulnes-Enriquez, Isabel; Jimenez, Xochitl; Hemandez, Gustavo; De La Rosa, Roxana; Yun Chon; Huiying Yang; Nicholas, Susanne B.; Modilevsky, Tamara; Yu, Katherine; Van Herle, Katja; Castellani, Lawrence W.; Elashoff, Robert; Hsueh, Willa A.; Quiñones, Manuel J; Hernandez-Pampaloni, Miguel; Hernandez, Gustavo; Chon, Yun // Annals of Internal Medicine;5/4/2004, Vol. 140 Issue 9, p700 

    Background: Insulin resistance is a metabolic spectrum that progresses from hyperinsulinemia to the metabolic syndrome, impaired glucose tolerance, and finally type 2 diabetes mellitus. It is unclear when vascular abnormalities begin in this spectrum of metabolic...

  • How to Implement Evidence Into Practice to Improve Diabetes Care. Saleem, Tipu Faiz M. // Diabetes Care;Mar2004, Vol. 27 Issue 3, p849 

    Presents a comment on the study related to the treatment of diabetes disease. Analysis on the blood samples of the patients; Increase risks of hypertension; Level of survival.

  • Intensive control of type 1 diabetes results in fewer cardiovascular events over the long term.  // Formulary;Mar2006, Vol. 41 Issue 3, p144 

    The article discusses the long-lasting cardiovascular benefits of intensive glucose control among patients with type 1 diabetes. A study made by the Diabetes Control and Complications Trial (DCCT) reveals that tight blood glucose control for a mean of 6.5 years followed by less intensive control...

  • Association Between Impaired Cardiovascular Autonomic Function and Hypoglycemia in Patients With Type 1 Diabetes. Jaiswal, Mamta; McKeon, Katherine; Comment, Nicholas; Henderson, James; Swanson, Scott; Plunkett, Cynthia; Nelson, Patrick; Pop-Busui, Rodica // Diabetes Care;Sep2014, Vol. 37 Issue 9, p2616 

    OBJECTIVE We studied the association between glycemic variability (GV) reflecting hypoglycemic stress and cardiovascular autonomic function in subjects with type 1 diabetes. RESEARCH DESIGN AND METHODS Forty-four type 1 diabetic patients (mean age 34 ± 13 years, 40% male, 86% Caucasian, mean...

  • Drugs for preventing cardiovascular disease in China. Jin Ling Tang; Yong Hua Hu // BMJ: British Medical Journal (International Edition);3/19/2005, Vol. 330 Issue 7492, p610 

    Focuses on strategies for treating cardiovascular disease in China. Difficulty of focusing on prevention of cardiovascular disease based on risk factors due to the large prevalence of the disease and the limited healthcare resources in China; Prevalence rates for hypertension, hyperlipodaemia,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics